Agenus (AGEN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AGEN Agenus

Watchlist

3.760
+0.100+2.73%

Close Jan 23 16:00 ET

3.760
0.0000.00%

Post 18:27 ET

88.78MMarket Cap-0.34P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

What Makes Agenus (AGEN) a New Buy Stock
Yahoo FinanceJan 20 12:00 ET
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
Yahoo FinanceJan 20 09:40 ET
Catalyst Watch: Netflix Earnings, Monster Beverage Event, Drug Data, and Quantum Volatility
Seeking AlphaJan 17 15:00 ET
$960 Mn Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine - Global Forecast to 2029 With GSK, Seppic, Croda, SPI Pharma, Phibro Animal Health, Agenus, Dynavax Technologies Dominating
Yahoo FinanceJan 8 09:32 ET
B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsJan 7 08:31 ET · Ratings
Express News | Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
BenzingaDec 18, 2024 07:35 ET

Comments

Jaguar8

Yesterday 04:47

NEWS

$Agenus (AGEN.US)$
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
Wednesday, 22nd January at 2:48 pm
• Results from two independent neoadjuvant studies in the U.S. and Europe, enrolling more than 80 patients, underscore BOT/BAL's potential to enable chemo-free and non-operative approaches in colorectal cancer (CRC).
• New randomized Phase 2 results in over 230 patients with refractory MSS mCRC, consistent with Pha...

Trytosaveabit

Dec 18, 2024 06:40

Update

$Agenus (AGEN.US)$ Benzinga· 3 mins ago
Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

Jaguar8

Dec 5, 2024 06:32

NEWS

$Agenus (AGEN.US)$
Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
1 minute ago, 4:30 AM PST
Via BusinessWire
Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the advancement of its most impactful programs as it prepares for 2025. Reductions are designed to reduce cash burn to $100 million in FY 2025. T...

Jaguar8

Nov 27, 2024 07:15

NEWS

$Agenus (AGEN.US)$
Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
Agenus (NASDAQ: AGEN) has secured a $22 million mortgage backed by its Berkeley and Vacaville properties, providing $20 million in net proceeds.
The two-year mortgage includes interest payable 50% in cash and 50% in common stock, at rates of 12% for Year 1 and 13% for Year 2.
The company announced a Strategic Operational Realignment Plan focusing on botensilimab/balstilimab(BOT/BAL) in MSS...